Skip to the content
info@appilitherapeutics.com
Get in Touch
Home
Pipeline
Strategy
About Us
Investors
News & Events
Contact
Menu
Home
Pipeline
Strategy
About Us
Investors
News & Events
Contact
NEWS
Archives 2017
News
Highlights
News
2024
News
2023
News
2022
Archives
2016-2021
Media
Contact
Media And
Events
News
Highlights
News
2024
News
2023
News
2022
Archives
2016-2021
Media
Contact
Media And
Events
Archives 2021
Archives 2020
Archives 2019
Archives 2018
Archives 2017
Archives 2016
Archives 2021
Archives 2020
Archives 2019
Archives 2018
Archives 2017
Archives 2016
November 28, 2017
Appili Therapeutics Appoints Seasoned Biotech Executive Ian C. Mortimer to its Board
Read More
November 7, 2017
Appili Therapeutics Receives $1.2M USD from the Department of Defense to Advance Antibiotic Targeting Drug-Resistant Bacteria
Read More
October 30, 2017
Appili Receives FDA and Health Canada Clearance to Begin Clinical Trials of its Antibiotic Oral Liquid Reformulation
Read More
October 23, 2017
Appili Therapeutics Raises $3M to Advance Its Anti-Infective Pipeline
Read More
September 8, 2017
Appili Announces Results of 2017 AGM
Read More
July 6, 2017
Appili Therapeutics Inc. Appoints Pharmaceutical Executive Sean McBride as Vice President, Business Development
Read More
April 19, 2017
Appili Therapeutics To Present at the Bloom Burton & Co. Healthcare Investor Conference
Read More
April 11, 2017
Appili Therapeutics Receives Funding from the Government of Canada to Support Development of New Antibiotic To Treat Gram-Negative Infections
Read More
February 17, 2017
Appili Therapeutics Awarded $2.8M From ACOA to Fund Clinical Trials
Read More
January 6, 2017
Appili Therapeutics Inc. Appoints Industry Veteran Stephen Nicolle to its Board
Read More
